GlobeNewswire Inc.··Pharming Group N.V.Pharming Wins Japan Approval for Joenja, First APDS Treatment for Young Children
Pharming secures Japan approval for Joenja, first APDS treatment for children aged 4-11 globally, based on positive Phase III data showing lymphadenopathy reduction and immune function improvement.
PHARpediatric treatmentorphan drug